Stockreport

Cyclerion to Present at the Evercore ISI 2nd Annual HealthCONx Conference

Cyclerion Therapeutics, Inc.  (CYCN) 
PDF CAMBRIDGE, Mass., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the development [Read more]